Summary
Patient-derived stem cells can now model individual genetic variations, enabling personalized drug testing for autism, epilepsy, and schizophrenia without ethical constraints. Gene editing and cell transplantation show promise, but be wary of unproven commercial stem cell therapies - rigorous validation is still needed before most human applications.
Key Points
- Autism diagnoses have risen dramatically, with genetic factors playing a significant role alongside environmental contributions
- Pasca pioneered "organoids and assembloids"—human stem cell-derived models that recreate brain structures and circuits for disease study and drug testing
- Reprogramming adult cells into pluripotent stem cells using Yamanaka factors enables personalized disease modeling without ethical constraints of embryonic sources
- Patient-derived stem cells allow researchers to model individual genetic variations, potentially enabling customized treatment strategies
- The discussion addresses risks of unproven stem cell therapies and emphasizes rigorous scientific validation before human applications
- Specific genetic conditions like Timothy syndrome demonstrate how assembloids can identify disease mechanisms and test potential therapeutic interventions
- Cell transplantation and gene editing approaches show promise for treating autism, epilepsy, and schizophrenia, though significant research remains needed
Key Moments
Autism prevalence approaching 3% and is not one disease
Dr. Serju Pasca explains that autism prevalence has risen to nearly 3% of the population, up from being considered a rare disease. He compares it to fever in the 19th century, where one symptom encompassed many different underlying conditions with very different treatments. The male-to-female ratio is about 4:1.
"Now it's close to almost 3% of the general population, which, of course, it's a big number."
Growing mini-brains from skin cells to study autism
Dr. Pasca pioneered the development of brain organoids and assembloids, miniature brain structures grown from stem cells that allow researchers to understand exactly what goes wrong in psychiatric illnesses like profound autism and schizophrenia, and to develop cures.
"Those organoids and assembloids are immensely powerful for understanding exactly what is wrong in psychiatric illnesses like profound autism, schizophrenia, and other psychiatric challenges, and for developing cures."
Children with autism sometimes speak in sentences during fever
There are anecdotic reports of nonverbal autistic children who suddenly start speaking in sentences during high fever. Hypotheses include adrenergic system activation, immune cytokines entering the brain, or ion channels opening more at higher temperatures.
"There are a few reports of parents saying that when they spike the very high fever, they'll start talking in sentences, like very briefly, or like engage."
